Edaravone 89-25-8
Edaravone (Radicut) is a neuroprotective agent used for the purpose of aiding neurological recovery following acute brain ischemia and subsequent cerebral infarction. It acts as a potent antioxidant and strongly scavenges free radicals, protecting against oxidative stress and neuronal apoptosis. It has been marketed solely in Japan by Mitsubishi Pharma since 2001. Edaravone has been shown to attenuate methamphetamine- and 6-OHDA-induced dopaminergic neurotoxicity in the striatum and substantia nigra, and does not affect methamphetamine-induced dopamine release or hyperthermia.
read more [+]| Systematic (IUPAC) name: | 5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one |
|---|---|
| Edaravone CAS number: | 89-25-8 |
| ATC code: | |
| PubChem: | 4021 |
| DrugBank: | |
| Formula: | C10H10N2O1 |
| Molecular mass: | 174.20 g/mol |
| Edaravone Assay/Purity: | Typically NLT 98% |
